Cargando…
Formative usability evaluation of a fixed-dose pen-injector platform device
BACKGROUND: This article for the first time presents a formative usability study of a fixed-dose pen injector platform device used for the subcutaneous delivery of biopharmaceuticals, primarily for self-administration by the patient. The study was conducted with a user population of both naïve and e...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894723/ https://www.ncbi.nlm.nih.gov/pubmed/29670411 http://dx.doi.org/10.2147/MDER.S159733 |
_version_ | 1783313543420968960 |
---|---|
author | Lange, Jakob Nemeth, Tobias |
author_facet | Lange, Jakob Nemeth, Tobias |
author_sort | Lange, Jakob |
collection | PubMed |
description | BACKGROUND: This article for the first time presents a formative usability study of a fixed-dose pen injector platform device used for the subcutaneous delivery of biopharmaceuticals, primarily for self-administration by the patient. The study was conducted with a user population of both naïve and experienced users across a range of ages. The goals of the study were to evaluate whether users could use the devices safely and effectively relying on the instructions for use (IFU) for guidance, as well as to benchmark the device against another similar injector established in the market. Further objectives were to capture any usability issues and obtain participants’ subjective ratings on the properties and performance of both devices. METHODS: A total of 20 participants in three groups studied the IFU and performed simulated injections into an injection pad. RESULTS: All participants were able to use the device successfully. The device was well appreciated by all users with, maximum usability feedback scores reported by 90% or more on handling forces and device feedback, and by 85% or more on fit and grip of the device. The presence of clear audible and visible feedbacks upon successful loading of a dose and completion of injection was seen to be a significant improvement over the benchmark injector. CONCLUSION: The observation that the platform device can be safely and efficiently used by all user groups provides confidence that the device and IFU in their current form will pass future summative testing in specific applications. |
format | Online Article Text |
id | pubmed-5894723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-58947232018-04-18 Formative usability evaluation of a fixed-dose pen-injector platform device Lange, Jakob Nemeth, Tobias Med Devices (Auckl) Original Research BACKGROUND: This article for the first time presents a formative usability study of a fixed-dose pen injector platform device used for the subcutaneous delivery of biopharmaceuticals, primarily for self-administration by the patient. The study was conducted with a user population of both naïve and experienced users across a range of ages. The goals of the study were to evaluate whether users could use the devices safely and effectively relying on the instructions for use (IFU) for guidance, as well as to benchmark the device against another similar injector established in the market. Further objectives were to capture any usability issues and obtain participants’ subjective ratings on the properties and performance of both devices. METHODS: A total of 20 participants in three groups studied the IFU and performed simulated injections into an injection pad. RESULTS: All participants were able to use the device successfully. The device was well appreciated by all users with, maximum usability feedback scores reported by 90% or more on handling forces and device feedback, and by 85% or more on fit and grip of the device. The presence of clear audible and visible feedbacks upon successful loading of a dose and completion of injection was seen to be a significant improvement over the benchmark injector. CONCLUSION: The observation that the platform device can be safely and efficiently used by all user groups provides confidence that the device and IFU in their current form will pass future summative testing in specific applications. Dove Medical Press 2018-04-04 /pmc/articles/PMC5894723/ /pubmed/29670411 http://dx.doi.org/10.2147/MDER.S159733 Text en © 2018 Lange and Nemeth. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Lange, Jakob Nemeth, Tobias Formative usability evaluation of a fixed-dose pen-injector platform device |
title | Formative usability evaluation of a fixed-dose pen-injector platform device |
title_full | Formative usability evaluation of a fixed-dose pen-injector platform device |
title_fullStr | Formative usability evaluation of a fixed-dose pen-injector platform device |
title_full_unstemmed | Formative usability evaluation of a fixed-dose pen-injector platform device |
title_short | Formative usability evaluation of a fixed-dose pen-injector platform device |
title_sort | formative usability evaluation of a fixed-dose pen-injector platform device |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894723/ https://www.ncbi.nlm.nih.gov/pubmed/29670411 http://dx.doi.org/10.2147/MDER.S159733 |
work_keys_str_mv | AT langejakob formativeusabilityevaluationofafixeddosepeninjectorplatformdevice AT nemethtobias formativeusabilityevaluationofafixeddosepeninjectorplatformdevice |